A Study to Assess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® Vaccine in Healthy Volunteers

Clinical trial NCT01591837 · COMPLETED

Trial details

NCT number: NCT01591837
Sponsor: Seqirus
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2012-05-01
Primary completion: 2012-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.